Options Research

Compare current setups

Put up to five tickers on the same scale. The comparison separates directional pressure, participation, volatility, trend agreement and data quality.

Return to Options Radar

Maximum five tickers. Scores measure evidence alignment, not the probability of a gain.

Strongest evidence alignment AKTS 52/100

The highest composite alignment across pressure, participation, trend fit and volatility.

Widest priced move AKTS 25.8%

The largest near-term move currently implied by the retained chain.

Strongest participation AKTS 3/100

The most active setup relative to open interest and contract-level flow.

Cleanest evidence AKTS A · 97/100

The comparison member with the strongest underlying, chain, quote and volatility coverage.

Side-by-side evidence

One scale, comparable inputs

1 current setups
Ticker Read Conviction Pressure Participation Volatility Trend fit Expected move Put-call Volume/OI Evidence
AKTSAktis Oncology, Inc. Common stock Volatility 52 -100 3 96 0 25.8% - 0.05 A97/100
Volatility

AKTS

Aktis Oncology, Inc. Common stock

52
Priced range 16.37–27.77
Pressure
-100
Participation
3
Trend fit
0
Reference IV
1.28

Options imply 16.37 to 27.77. Max pain at 22.50 sits inside that range, 1.9% above spot.

Open AKTS research